Supportive treatment in non-small cell lung cancer
| ISRCTN | ISRCTN96733516 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN96733516 |
| Secondary identifying numbers | LU17 |
- Submission date
- 28/02/2001
- Registration date
- 28/02/2001
- Last edited
- 19/02/2018
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Danielle Andrews
Scientific
Scientific
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom
| Phone | +44 (0)20 7636 5422 |
|---|---|
| clinical.trial@headoffice.mrc.ac.uk |
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Quality of life |
| Participant information sheet | Not available in web format, please use the contact details to request a patient information sheet |
| Scientific title | Supportive treatment in non-small cell lung cancer |
| Study objectives | To compare supportive treatment with or without immediate thoracic radiotherapy in the prevention & palliation of symptoms in patients with inoperable non small cell lung cancer. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Non small cell lung cancer |
| Intervention | 1. One group receives immediate thoracic radiotherapy 2. The other will have radiotherapy delayed until clinically indicated |
| Intervention type | Other |
| Primary outcome measure | 1. Palliation 2. Quality of life 3. Other 4. Survival time |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 09/10/1992 |
| Completion date | 31/05/1999 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 230 - all patients followed up until death |
| Key inclusion criteria | 1. No compelling indication for immediate thoracic radiotherapy 2. No previous treatment for the current lung cancer, either sex, and age |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 09/10/1992 |
| Date of final enrolment | 31/05/1999 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom
NW1 2DA
United Kingdom
Sponsor information
Medical Research Council (MRC) (UK)
Research council
Research council
20 Park Crescent
London
W1B 1AL
United Kingdom
| Phone | +44 (0)20 7636 5422 |
|---|---|
| clinical.trial@headoffice.mrc.ac.uk | |
| Website | http://www.mrc.ac.uk |
Funders
Funder type
Research council
Medical Research Council (MRC) (UK)
Government organisation / National government
Government organisation / National government
- Alternative name(s)
- Medical Research Council (United Kingdom), UK Medical Research Council, MRC
- Location
- United Kingdom
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Editorial Notes
19/02/2018: No publications found, verifying study status with principal investigator.
17/11/2015: No publications found in PubMed.
